Cargando…
Treatment of refractory complex partial seizures: role of vigabatrin
Vigabatrin (VGB) is an antiepileptic drug that was designed to inhibit GABA-transaminase, and increase levels of γ-amino-butyric acid (GABA), a major inhibitory neurotransmitter in the brain. VGB has demonstrated efficacy as an adjunctive antiepileptic drug for refractory complex partial seizures (C...
Autores principales: | Waterhouse, Elizabeth J, Mims, Kimberly N, Gowda, Soundarya N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762367/ https://www.ncbi.nlm.nih.gov/pubmed/19851518 |
Ejemplares similares
-
Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms
por: Lerner, Jason T, et al.
Publicado: (2010) -
Tiagabine: efficacy and safety in partial seizures – current status
por: Bauer, Jürgen, et al.
Publicado: (2008) -
Zonisamide – a review of experience and use in partial seizures
por: Wilfong, Angus A, et al.
Publicado: (2006) -
Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures
por: Weisenberg, Judith LZ, et al.
Publicado: (2011) -
Vigabatrin (Sabril) for the Treatment of Refractory Complex Focal Seizures in Adults: Pharmacologic and Clinical Considerations
por: Gatson, Taylor N, et al.
Publicado: (2023)